NCI Community Oncology Research Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer Laboratory Biomarker Analysis, Naloxegol, Placebo, Quality-of-Life Assessment NCT03087708 Alliance for Clinical Trials in Oncology Active, not recruiting
National Cancer Institute "Cancer Moonshot Biobank" Biospecimen Collection, Medical Chart Review NCT04314401 National Cancer Institute (NCI) Recruiting
NCI COVID-19 in Cancer Patients, NCCAPS Study Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration NCT04387656 National Cancer Institute (NCI) Active, not recruiting
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or... Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment NCT03367572 University of Rochester NCORP Research Base Recruiting
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by... Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration NCT03757949 Southwest Oncology Group Recruiting
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer... Megestrol Acetate, Olanzapine, Questionnaire Administration NCT04939090 Alliance for Clinical Trials in Oncology Recruiting
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and... Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Ondansetron Hydrochloride, Palonosetron Hydrochloride, Placebo NCT03578081 Alliance for Clinical Trials in Oncology Active, not recruiting
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2... Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment NCT03633331 Alliance for Clinical Trials in Oncology Active, not recruiting
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil Donepezil 5 mg, Placebo NCT02822573 Wake Forest University Health Sciences Active, not recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 International Breast Cancer Study Group Active, not recruiting

Pages